How Monoclonal Antibodies Affect B-Cell Growth
Author Information
Author(s): Cragg M S, Zhang L, French R R, Glennie M J
Primary Institution: Tenovus Research Laboratory, Southampton General Hospital
Hypothesis
The study investigates how monoclonal antibodies interact with surface IgM on neoplastic B-cells and their effect on cell growth.
Conclusion
The effectiveness of monoclonal antibodies in inhibiting B-cell growth is highly dependent on the crosslinking of surface IgM.
Supporting Evidence
- Three Burkitts lymphoma cell lines were identified that were inhibited by anti-IgM antibody.
- Growth inhibition was highly dependent on the extent of IgM crosslinking.
- Monoclonal antibodies specific for the Fc region were more effective than those recognizing the Fab region.
Takeaway
This study found that certain antibodies can stop cancer cells from growing, but they work better when they can link together more effectively.
Methodology
In vitro studies were conducted using three Burkitts lymphoma cell lines to assess the effects of various monoclonal antibodies on cell growth.
Participant Demographics
The study involved three Burkitts lymphoma cell lines: Ramos, MUTU-I, and Daudi.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website